Cargando…

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis

BACKGROUND: In hormone-receptor positive/HER2-negative metastatic breast cancer (mBC) no randomized comparisons are available between CDK4/6 inhibitors. We undertook this systematic review and meta-analysis to assess the reliability of the likelihood of being helped or harmed (LHH). METHODS: PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mastrantoni, Luca, Orlandi, Armando, Palazzo, Antonella, Garufi, Giovanna, Fabi, Alessandra, Daniele, Gennaro, Giannarelli, Diana, Tortora, Giampaolo, Bria, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874016/ https://www.ncbi.nlm.nih.gov/pubmed/36713467 http://dx.doi.org/10.1016/j.eclinm.2023.101824

Ejemplares similares

The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature
por: Garufi, Giovanna, et al.
Publicado: (2021)

Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
por: Mastrantoni, Luca, et al.
Publicado: (2023)

Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence.
por: Garufi, Giovanna, et al.
Publicado: (2020)

Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response
por: Pasqualoni, Mariangela, et al.
Publicado: (2023)

Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series †
por: Orlandi, Armando, et al.
Publicado: (2020)

Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
por: Garufi, Giovanna, et al.
Publicado: (2023)

Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
por: Orlandi, Armando, et al.
Publicado: (2021)

Treatment of Locally Advanced Gastric Cancer (LAGC): Back to Lauren’s Classification in Pan–Cancer Analysis Era?
por: Zurlo, Ina Valeria, et al.
Publicado: (2020)

Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings
por: Lombardi, Pasquale, et al.
Publicado: (2023)

Definition of a tool to assess shared decision‐making (SDM) on women with breast cancer: A value‐based approach
por: Angioletti, Carmen, et al.
Publicado: (2022)

Evaluating the likelihood to be helped or harmed after treatment with viloxazine extended‐release in children and adolescents with attention‐deficit/hyperactivity disorder
por: Nasser, Azmi, et al.
Publicado: (2021)

Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
por: Citrome, Leslie, et al.
Publicado: (2022)

Development of a Digital Research Assistant for the Management of Patients’ Enrollment in Oncology Clinical Trials within a Research Hospital
por: Cesario, Alfredo, et al.
Publicado: (2021)

Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
por: Citrome, Leslie, et al.
Publicado: (2022)

Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents
por: Garufi, Giovanna, et al.
Publicado: (2022)

Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
por: Marazzi, Fabio, et al.
Publicado: (2020)

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
por: Carbognin, Luisa, et al.
Publicado: (2015)

Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
por: Cencioni, Chiara, et al.
Publicado: (2022)

PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives
por: Fuso, Paola, et al.
Publicado: (2022)

A strong dollar: help or harm?
por: Dollar, David, et al.
Publicado: (2020)

Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
por: Vita, Emanuele, et al.
Publicado: (2021)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Antiapoptotic Molecule Survivin in Transplantation: Helpful or Harmful?
por: Assadiasl, Sara, et al.
Publicado: (2018)

Fruit Juices: Are They Helpful or Harmful? An Evidence Review
por: Ruxton, Carrie H. S., et al.
Publicado: (2021)

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
por: Bonomi, Maria, et al.
Publicado: (2011)

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors
por: Santoni, Matteo, et al.
Publicado: (2014)

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
por: Piro, Geny, et al.
Publicado: (2019)

PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target
por: Salvatore, Lisa, et al.
Publicado: (2019)

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives
por: Ferrara, Miriam Grazia, et al.
Publicado: (2020)

Professional Support After Partner Loss: Likelihood and Correlates of Help-Seeking Behavior
por: Jopp, Daniela S., et al.
Publicado: (2021)

Do early therapies help very young children with or at high likelihood for autism?
Publicado: (2022)

Do early therapies help very young children with or at high likelihood for autism?
Publicado: (2022)

Predicting review helpfulness in the omnichannel retailing context: An elaboration likelihood model perspective
por: Zhang, Zhebin, et al.
Publicado: (2022)

Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting
por: Franco, Antonio, et al.
Publicado: (2023)

Improving the likelihood of neurology patients being examined using patient feedback
por: Appleton, Jason Philip, et al.
Publicado: (2015)

Identifying Genes that Help One Sex but Harm the Other
por: Meadows, Robin
Publicado: (2010)

Competition among health care providers: helpful or harmful?
por: Barros, Pedro Pita, et al.
Publicado: (2015)

RBM10: Harmful or helpful‐many factors to consider
por: Loiselle, Julie J., et al.
Publicado: (2018)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
por: Edmiston, Marissa K., et al.
Publicado: (2018)

Epinephrine in Out-of-hospital Cardiac Arrest: Helpful or Harmful?
por: Shao, Huan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b5iqr480i6t4s6669eq29btbdp